Curis Enhances Safety Culture with New VP Appointment at Michael Baker International
- Michael Baker International appointed Aaron Gies as Vice President of Health and Safety to enhance workplace safety culture.
- Gies aims to strengthen health and safety programs, aligning them with the company’s growth objectives and core values.
- The firm seeks to exceed industry safety standards and foster shared responsibility among employees for their safety.
Strengthening Safety Culture at Michael Baker International
In a significant move to bolster workplace safety, Michael Baker International appoints Aaron Gies as Vice President of Health and Safety on March 19, 2025. Gies steps into this pivotal role during a time when enhancing the company's safety culture is paramount. He is tasked with reinforcing the existing health and safety programs and policies, aligning these initiatives with the firm’s growth objectives. Gies’s appointment comes as part of a strategic effort to ensure that safety remains at the forefront of the company’s operations, reflecting the commitment to providing a secure work environment for all employees.
Gies's extensive background positions him well to lead this transformative initiative. Previously serving as Regional Safety Director for Infrastructure Southeast & General Building at MasTec Clean Energy & Infrastructure, he brings a wealth of experience managing safety across various sectors, including data centers, mining, and transportation infrastructure. His previous roles in senior management at reputable companies like William Charles Construction Company and Aldridge Electric have equipped him with the skills necessary to oversee complex safety initiatives. By engaging with Operations leaders and field personnel, Gies aims to galvanize the Corporate Safety Council, which will focus on implementing effective safety strategies across the organization.
Daniel Filer, Executive Vice President of Operations at Michael Baker, emphasizes the company’s unwavering commitment to workplace safety, aspiring for a culture devoid of preventable incidents. This vision aligns with the company’s core corporate values, which prioritize employee health and safety. Gies’s leadership is expected to foster a sense of shared responsibility among employees, encouraging them to take ownership of their safety and that of their colleagues. As Michael Baker International navigates its growth trajectory, the integration of robust safety practices is set to play a crucial role in maintaining operational excellence.
In addition to Gies’s appointment, Michael Baker International’s ongoing focus on safety reflects broader industry trends where companies increasingly prioritize employee wellbeing. The construction and engineering sectors are under mounting pressure to comply with stringent safety regulations, making effective leadership in health and safety a critical component of operational success.
As the firm integrates Gies’s expertise into its safety framework, stakeholders can anticipate a renewed emphasis on creating a culture that not only meets but exceeds industry standards for health and safety. This proactive approach not only safeguards employees but also enhances the company’s reputation as a leader in the engineering and consulting landscape.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

